| Issue Date | Title | Author(s) |
| 2023-05-17 | Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. | Moles, E; Howard, CB; Huda, P; Karsa, M; McCalmont, H; Kimpton, K; Duly, A; Chen, Y; Huang, Y; Tursky, ML; Ma, D; Bustamante, S; Pickford, R; Connerty, P; Omari, S; Jolly, CJ; Joshi, S; Shen, S; Pimanda, JE; Dolnikov, A; Cheung, LC; Kotecha, RS; Norris, MD; Haber, M; de Bock, CE; Somers, K; Lock, RB; Thurecht, KJ; Kavallaris, M |
| 2016-10-01 | The miRNA biogenesis factors, p72/DDX17 and KHSRP regulate the protein level of Ago2 in human cells | Connerty, P; Bajan, S; Remenyi, J; Fuller-Pace, FV; Hutvagner, G |
| 2015-12-26 | RNA Binding Proteins in the miRNA pathway | Connerty, P; Ahadi, A; Hutvagner, G |
| 2020-12 | Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia. | Dun, MD; Mannan, A; Rigby, CJ; Butler, S; Toop, HD; Beck, D; Connerty, P; Sillar, J; Kahl, RGS; Duchatel, RJ; Germon, Z; Faulkner, S; Chi, M; Skerrett-Byrne, D; Murray, HC; Flanagan, H; Almazi, JG; Hondermarck, H; Nixon, B; De Iuliis, G; Chamberlain, J; Alvaro, F; de Bock, CE; Morris, JC; Enjeti, AK; Verrills, NM |
| 2020-08 | Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia. | Salik, B; Yi, H; Hassan, N; Santiappillai, N; Vick, B; Connerty, P; Duly, A; Trahair, T; Woo, AJ; Beck, D; Liu, T; Spiekermann, K; Jeremias, I; Wang, J; Kavallaris, M; Haber, M; Norris, MD; Liebermann, DA; D'Andrea, RJ; Murriel, C; Wang, JY |
